The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort.
 
Mathilde Cancel
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; bristol-myers squibb; Ipsen; LEO Pharma; Lilly; MSD; Pfizer
 
Jérémie Naffrichoux
No Relationships to Disclose
 
Pierre Poupin
No Relationships to Disclose
 
William Pouillot
No Relationships to Disclose
 
Claude Linassier
Employment - Bayer (I)
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Pfizer
 
Nathalie Rioux-Leclercq
No Relationships to Disclose
 
Manon De Vries-Brilland
No Relationships to Disclose
 
Loic Mourey
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; BMS; Ipsen; janssen; Pfizer; Sanofi
 
Brigitte Laguerre
Honoraria - Astellas Pharma; Bayer; Bayer; Bayer; Eisai; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer
 
Stephane Oudard
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN,; Janssen; Merck; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - IPSEN,; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN,; Janssen; Merck; MSD; Novartis; Pfizer; Roche; Sanofi
 
Marine Gross-Goupil
No Relationships to Disclose
 
Gwenaelle Gravis
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); BMS (Inst); Curium Pharma (Inst); Janssen (Inst); Merck/Pfizer (Inst)
Speakers' Bureau - Advanced Accelerator Applications (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst)
Research Funding - BMS (Inst)
Expert Testimony - BAYER (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Pfizer
 
Frederic Rolland
Consulting or Advisory Role - Eisai; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Merck KGaA; Merck KGaA; MSD Oncology; Mundipharma; Pfizer
 
Laura Moise
No Relationships to Disclose
 
Sheik Muhummud Fardeen Emambux
No Relationships to Disclose
 
Cecile Vassal
No Relationships to Disclose
 
Sylvie Zanetta
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen; MSD; Pfizer
 
Gaelle Fromont
No Relationships to Disclose